Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 Mpro
Molecules · 16.01.2025 · 30 (2) · 351
DOI: 10.3390/molecules30020351 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 16.01.2025. Verfasst von Jiayi Ren und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Coronavirus 3C Proteases, Viral Nonstructural Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Natural Science Foundation of Southwest Medical University, Talent Recruitment Program of Southwest Medical University, The College Student Innovation and Entrepreneurship Training Program.
Abstract (Originalsprache)
The three-year COVID-19 pandemic ‘has’ caused a wide range of medical, social, political, and financial implications. Since the end of 2020, various mutations and variations in SARS-CoV-2 strains, along with the immune escape phenomenon, have emerged. There is an urgent need to identify a relatively stable target for the development of universal vaccines and drugs that can effectively combat both SARS-CoV-2 strains and their mutants. Currently, the main focus in treating SARS-CoV-2 lies in disrupting the virus’s life cycle. The main protease (Mpro) is closely associated with virus replication and maturation and plays a crucial role in the early stages of infection. Consequently, it has become an important target for the development of SARS-CoV-2-specific drugs. This review summarizes the recent research progress on the novel coronavirus’s main proteases, including the pivotal role of Mpro in the virus’s life cycle, the structure and catalytic mechanism of Mpro, the self-maturation mechanism of Mpro, the role of Mpro in virus immune escape, the current methods of developing antiviral drugs targeting Mpro, and the key drugs that have successfully entered clinical trials. The aim is to provide researchers involved in the development of antiviral drugs targeting Mpro with systematic and comprehensive information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China.
ORCID-Profile: Shujun Zhang
Förderung
- The Natural Science Foundation of Southwest Medical University
- Talent Recruitment Program of Southwest Medical University
- The College Student Innovation and Entrepreneurship Training Program
- Natural Science Foundation of Southwest Medical University
- College Student Innovation and Entrepreneurship Training Program
Zitieren
APA
Ren, J., Zhang, Z., Xia, Y., Zhao, D., Li, D., & Zhang, S. (2025). Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 Mpro. Molecules, 30(2), 351. https://doi.org/10.3390/molecules30020351
Vancouver
Ren J, Zhang Z, Xia Y, Zhao D, Li D, Zhang S. Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 Mpro. Molecules. 2025;30(2):351. doi:10.3390/molecules30020351
BibTeX
@article{Ren2025,
author = {Ren, Jiayi and Zhang, Zhengfu and Xia, Yi and Zhao, Daqun and Li, Dingqin and Zhang, Shujun},
title = {Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 Mpro},
journal = {Molecules},
year = {2025},
volume = {30},
number = {2},
pages = {351},
doi = {10.3390/molecules30020351}
}
EUVIMED